SEC Comment Letter 0000000000-23-003562 to Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd.
Date: April 10, 2023 · CIK: 0001871321 · Accession: 0000000000-23-003562
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271073
Letter
United States securities and exchange commission logo April 10, 2023 Uzi Sofer Chief Executive Officer and Chairman Alpha Tau Medical Ltd. Kiryat HaMada St. 5 Jerusalem, Israel 9777605 Re:Alpha Tau Medical Ltd. Registration Statement on Form F-3 Filed April 3, 2023 File No. 333-271073 Dear Uzi Sofer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Michael J. Rosenberg
Show Raw Text
United States securities and exchange commission logo
April 10, 2023
Uzi Sofer
Chief Executive Officer and Chairman
Alpha Tau Medical Ltd.
Kiryat HaMada St. 5
Jerusalem, Israel 9777605
Re:Alpha Tau Medical Ltd.
Registration Statement on Form F-3
Filed April 3, 2023
File No. 333-271073
Dear Uzi Sofer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Michael J. Rosenberg